Loading cancer entity…
Loading cancer entity…
Clinical trials
8,120 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,290)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05514327 | A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL | recruiting | N/A | 20 | Peking Union Medical College HospitalOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT05866757 | Discontinuation Study | recruiting | N/A | 70 | University College CorkOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT06789003 |
| Evaluation of a PREHABilitation Protocol Using Adapted Physical Activity (APA) for Multiple Myeloma Patients Eligible for Intensive Autologous Stem Cell Transplantation Treatment(PREHAB-APA) |
| recruiting |
| N/A |
| 120 |
| Centre Hospitalier Henri Duffaut - AvignonOTHER |
| 1 |
| Mar 3, 2026 |
| clinicaltrials |
| NCT07445438 | Feasibility of a Multi-omics Platform for Hematological Malignancies(FOCUS) | recruiting | N/A | 1,040 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT07443514 | Cognitive Impairment in Patients With Diffuse Large B-Cell Lymphoma | recruiting | N/A | 3 | Institute of Oncology LjubljanaOTHER | 1 | Mar 2, 2026 | clinicaltrials |
| NCT05745285 | Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care | recruiting | N/A | 400 | University of MiamiOTHER | 1 | Feb 20, 2026 | clinicaltrials |
| NCT07342179 | CAR-T Immunomonitoring in Multiple Myeloma (CART I5M)(CART I5M) | recruiting | N/A | 60 | Poitiers University HospitalOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT07403630 | INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)(IT-TCP POS) | recruiting | N/A | 300 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT04368702 | CONFIRM: Magnetic Resonance Guided Radiation Therapy(CONFIRM) | recruiting | N/A | 70 | Brigham and Women's HospitalOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT06280924 | Prehab Prior to Stem Cell Transplantation in Multiple Myeloma(MOTIVATE) | recruiting | N/A | 30 | University of AlbertaOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT07390071 | Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy | recruiting | N/A | 40 | University of UtahOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT05839210 | Lifestyle Intervention of Food and Exercise for Lymphoma Survivors(LIFE-L) | recruiting | N/A | 140 | University of MiamiOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT06069830 | PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma(ENKTL) | recruiting | N/A | 89 | Ruijin HospitalOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT06693830 | ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL | recruiting | N/A | 40 | Hua-Jay J Cherng, MDOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT05706766 | Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation | recruiting | N/A | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT07044427 | Fall Risk Assessment and an Exercise Intervention for Prevention of Falls in Multiple Myeloma Patients(Myfall) | recruiting | N/A | 60 | University Hospital HeidelbergOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT06004011 | AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW) | recruiting | N/A | 4,100 | ImplenomicsOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT07100067 | LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma | recruiting | N/A | 35 | Nanjing Legend Biotech Co.INDUSTRY | 1 | Dec 29, 2025 | clinicaltrials |
| NCT05642884 | Prehabilitation Feasibility Among Older Adults Undergoing Transplantation | recruiting | N/A | 30 | Noha Mohamed SharafeldinOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT06247189 | ICOPE Program Feasibility in the Management of Myeloma Patients(Onco-ICOPE) | recruiting | N/A | 30 | University Hospital, ToulouseOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT06485076 | Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma(EPC-MM+L) | recruiting | N/A | 144 | University Health Network, TorontoOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT07257510 | Pomalidomide Plus Orelabrutinib and Zuberitamab in Untreated Mantle Cell Lymphoma | recruiting | N/A | 34 | Peking University Third HospitalOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT05312255 | Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma | recruiting | N/A | 175 | Roswell Park Cancer InstituteOTHER | 1 | Dec 1, 2025 | clinicaltrials |
| NCT07248176 | Universal CAR-T Cell Therapy for MM | recruiting | N/A | 6 | Bioray LaboratoriesINDUSTRY | 1 | Dec 1, 2025 | clinicaltrials |
| NCT06508775 | Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies(LONGSAFE) | recruiting | N/A | 40 | Miltenyi Biomedicine GmbHINDUSTRY | 1 | Nov 26, 2025 | clinicaltrials |
| NCT07248163 | Universal CAR-T Cell Therapy for NHL | recruiting | N/A | 6 | Bioray LaboratoriesINDUSTRY | 1 | Nov 25, 2025 | clinicaltrials |
| NCT07236021 | e-Motion : Promoting Emotion Regulation in Chronic Cancer | recruiting | N/A | 30 | Université Libre de BruxellesOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT02641145 | Molecular Imaging of Primary Amyloid Cardiomyopathy(MICA) | recruiting | N/A | 171 | Brigham and Women's HospitalOTHER | 1 | Nov 14, 2025 | clinicaltrials |
| NCT06055894 | A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS) | recruiting | N/A | 200 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 13, 2025 | clinicaltrials |
| NCT05940272 | Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers | recruiting | N/A | 48 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 9, 2025 | clinicaltrials |
| NCT06409767 | Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation.(ALHERT) | recruiting | N/A | 2,224 | University Hospital, AngersOTHER_GOV | 1 | Sep 24, 2025 | clinicaltrials |
| NCT06487247 | HEME Home Transfusion Program | recruiting | N/A | 700 | Dana-Farber Cancer InstituteOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT06133426 | Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients(BTP) | recruiting | N/A | 30 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT04893564 | Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenström Macroglobulinemia(SLP-rares) | recruiting | N/A | 90 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT06908629 | Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors | recruiting | N/A | 120 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT07126678 | Fixed-Duration Zanubrutinib, Bendamustine, and Obinutuzumab (ZBG) in Treatment-Naïve Advanced Stage Follicular Lymphoma | recruiting | N/A | 15 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 17, 2025 | clinicaltrials |
| NCT07074470 | Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL(VPX) | recruiting | N/A | 40 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Jul 20, 2025 | clinicaltrials |
| NCT07072208 | Pomalidomide, Rituximab and Orelabrutinib Combined With Polatuzumab Vedotin in the Treatment of Newly Diagnosed Elderly Patients With DLBCL | recruiting | N/A | 43 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT07072221 | Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients | recruiting | N/A | 40 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT07059741 | Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL | recruiting | N/A | 20 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT06871176 | PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM) | recruiting | N/A | 30 | University Health Network, TorontoOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT05618041 | The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies | recruiting | N/A | 50 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Jun 24, 2025 | clinicaltrials |
| NCT06940960 | JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia | recruiting | N/A | 20 | Affiliated Hospital of Guangdong Medical UniversityOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT05036564 | Diagnosis; Objective RespOnse; THErApy(DOROTHEA) | recruiting | N/A | 70 | IRCCS San RaffaeleOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT04898647 | Clinical Study of the Hyperviscosity Syndrome in Waldenström Macroglobulinemia(SLPRaresHvisc) | recruiting | N/A | 100 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | May 29, 2025 | clinicaltrials |
| NCT06890065 | JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia | recruiting | N/A | 20 | Shenzhen Genocury Biotech Co., Ltd.INDUSTRY | 1 | May 15, 2025 | clinicaltrials |
| NCT06946407 | Rituximab, Methotrexate, and Tepadina Induction Followed by Etoposide and Cytarabine Consolidation in Primary Central Nervous System Lymphoma | recruiting | N/A | 41 | FengYan JinOTHER | 1 | Apr 27, 2025 | clinicaltrials |
| NCT06699394 | Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis | recruiting | N/A | 20 | Peking University People's HospitalOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT05956457 | PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma | recruiting | N/A | 100 | Pack HealthINDUSTRY | 1 | Apr 20, 2025 | clinicaltrials |
| NCT02964858 | Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma.(DOBL) | recruiting | N/A | 840 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 11, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Mar 24, 2026source: clinicaltrials